These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 15619623)

  • 1. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity.
    Descargues P; Deraison C; Bonnart C; Kreft M; Kishibe M; Ishida-Yamamoto A; Elias P; Barrandon Y; Zambruno G; Sonnenberg A; Hovnanian A
    Nat Genet; 2005 Jan; 37(1):56-65. PubMed ID: 15619623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome.
    Descargues P; Deraison C; Prost C; Fraitag S; Mazereeuw-Hautier J; D'Alessio M; Ishida-Yamamoto A; Bodemer C; Zambruno G; Hovnanian A
    J Invest Dermatol; 2006 Jul; 126(7):1622-32. PubMed ID: 16628198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Netherton syndrome: report of two Taiwanese siblings with staphylococcal scalded skin syndrome and mutation of SPINK5.
    Chao SC; Richard G; Lee JY
    Br J Dermatol; 2005 Jan; 152(1):159-65. PubMed ID: 15656819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
    Fortugno P; Furio L; Teson M; Berretti M; El Hachem M; Zambruno G; Hovnanian A; D'Alessio M
    Hum Mol Genet; 2012 Oct; 21(19):4187-200. PubMed ID: 22730493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
    Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
    Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome.
    Hewett DR; Simons AL; Mangan NE; Jolin HE; Green SM; Fallon PG; McKenzie AN
    Hum Mol Genet; 2005 Jan; 14(2):335-46. PubMed ID: 15590704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins.
    Di WL; Hennekam RC; Callard RE; Harper JI
    Br J Dermatol; 2009 Aug; 161(2):404-12. PubMed ID: 19438860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and expression analysis of the Spink5 gene, the mouse ortholog of the defective gene in Netherton syndrome.
    Galliano MF; Roccasecca RM; Descargues P; Micheloni A; Levy E; Zambruno G; D'Alessio M; Hovnanian A
    Genomics; 2005 Apr; 85(4):483-92. PubMed ID: 15780751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules.
    Shimomura Y; Sato N; Kariya N; Takatsuka S; Ito M
    Br J Dermatol; 2005 Nov; 153(5):1026-30. PubMed ID: 16225619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome.
    Sales KU; Masedunskas A; Bey AL; Rasmussen AL; Weigert R; List K; Szabo R; Overbeek PA; Bugge TH
    Nat Genet; 2010 Aug; 42(8):676-83. PubMed ID: 20657595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
    Roedl D; Oji V; Buters JT; Behrendt H; Braun-Falco M
    J Dermatol Sci; 2011 Mar; 61(3):194-8. PubMed ID: 21251800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.
    Chavanas S; Bodemer C; Rochat A; Hamel-Teillac D; Ali M; Irvine AD; Bonafé JL; Wilkinson J; Taïeb A; Barrandon Y; Harper JI; de Prost Y; Hovnanian A
    Nat Genet; 2000 Jun; 25(2):141-2. PubMed ID: 10835624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.
    Hachem JP; Wagberg F; Schmuth M; Crumrine D; Lissens W; Jayakumar A; Houben E; Mauro TM; Leonardsson G; Brattsand M; Egelrud T; Roseeuw D; Clayman GL; Feingold KR; Williams ML; Elias PM
    J Invest Dermatol; 2006 Jul; 126(7):1609-21. PubMed ID: 16601670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition.
    Hovnanian A
    Cell Tissue Res; 2013 Feb; 351(2):289-300. PubMed ID: 23344365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome.
    Furio L; Pampalakis G; Michael IP; Nagy A; Sotiropoulou G; Hovnanian A
    PLoS Genet; 2015 Sep; 11(9):e1005389. PubMed ID: 26390218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.
    Egelrud T; Brattsand M; Kreutzmann P; Walden M; Vitzithum K; Marx UC; Forssmann WG; Mägert HJ
    Br J Dermatol; 2005 Dec; 153(6):1200-3. PubMed ID: 16307658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal differentiation: the role of proteases and their inhibitors.
    Zeeuwen PL
    Eur J Cell Biol; 2004 Dec; 83(11-12):761-73. PubMed ID: 15679120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LEKTI-1 in sickness and in health.
    Roelandt T; Thys B; Heughebaert C; De Vroede A; De Paepe K; Roseeuw D; Rombaut B; Hachem JP
    Int J Cosmet Sci; 2009 Aug; 31(4):247-54. PubMed ID: 19467033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
    Fortugno P; Bresciani A; Paolini C; Pazzagli C; El Hachem M; D'Alessio M; Zambruno G
    J Invest Dermatol; 2011 Nov; 131(11):2223-32. PubMed ID: 21697885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome.
    Briot A; Deraison C; Lacroix M; Bonnart C; Robin A; Besson C; Dubus P; Hovnanian A
    J Exp Med; 2009 May; 206(5):1135-47. PubMed ID: 19414552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.